Short and long daily sleep duration found to be risk factors for dementia, premature death

Short and long daily sleep duration were risk factors for dementia and premature death in a study of Japanese adults aged 60 years and older. The findings are published in the Journal of the American Geriatrics Society.

Among 1,517 adults who were followed for 10 years, 294 developed dementia and 282 died. Age- and sex-adjusted incidence rates of dementia and all-cause mortality were greater in those with daily sleep duration of less than 5.0 hours and 10.0 hours or more, compared with those with daily sleep duration of 5.0 to 6.9 hours. Participants with short sleep duration who had high physical activity did not have a greater risk of dementia and death, however.

"Given the beneficial effects of physical activity on risk of sleep disturbance, these findings indicate that not only maintenance of appropriate sleep duration, but also modification of lifestyle behaviors related to sleep may be an effective strategy for preventing dementia and premature death in elderly adults," the authors wrote.

Source: http://newsroom.wiley.com/press-release/journal-american-geriatrics-society/optimal-sleep-linked-lower-risks-dementia-and-earl

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New neuroimaging marker may identify persons at risk of dementia in future clinical trials